Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation.
Lladó
L
L
Liver Transplant Unit, C.S.U. Bellvitge, University of Barcelona, Barcelona, Spain.
Figueras
J
J
Ramos
E
E
Lama
C
C
Busquets
J
J
Ibáñez
L
L
Rafecas
A
A
Fabregat
J
J
Torras
J
J
Jaurrieta
E
E
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003404:Creatinine / Q000378:metabolism; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D008103:Liver Cirrhosis / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012449:Safety; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D003404:Creatinine; D001379:Azathioprine; D016559:Tacrolimus